AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15990345
Drug: Dosimeter method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dosimeter method with capsaicin 0.4 micromol/L
Trial: 8856838
Drug: Melatonin 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 1.0 mg
Trial: 6235249
Drug: Etodolac 400
RxNorm normalized name: etodolac 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac 400 mg b.i.d.
Trial: 6235249
Drug: Etodolac 600
RxNorm normalized name: etodolac 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac 600 mg b.i.d.
Trial: 6235249
Drug: Ibuprofen 600
RxNorm normalized name: ibuprofen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 600 mg q.i.d.
Trial: 6235249
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg in the morning, 50 mg at noon, and 100 mg h.s.
Trial: 6235249
Drug: Naproxen 375
RxNorm normalized name: naproxen 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 375 mg b.i.d.
Trial: 29514163
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) 2 mg/day for days 1-28 with regorafenib
Trial: 26820395
Drug: Heracleum persicum
RxNorm normalized name: Heracleum hemsleyanum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heracleum persicum hydroalcoholic fruit extract (300 mg/day)
Trial: 25634390
Drug: Nitroglycerin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin and lignocaine (3 ml solution) infiltrated subcutaneously at the site intended for puncture (Group NL)
Trial: 20602795
Drug: Modified constraint-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified constraint-induced movement therapy
Trial: 10422354
Drug: Holding therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Holding therapy
Trial: 7768080
Drug: Felodipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (2.5 to 20 mg) once daily
Trial: 7768080
Drug: Felodipine (oral)
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine (oral)
Trial: 1416266
Drug: Budesonide nasal
RxNorm normalized name: budesonide nasal
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide nasal spray, 100 micrograms per nostril twice a day
Trial: 3998201
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg (single dose)
Trial: 3998201
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg (multiple doses, 200 mg every six hours and 400 mg before retiring)
Trial: 3998201
Drug: Acetaminophen 750
RxNorm normalized name: acetaminophen 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 750 mg (single dose alone)
Trial: 30786924
Drug: Melanoma-associated antibodies
RxNorm normalized name: (264-l-valine)melanocyte protein pmel 17 (human melanoma-associated me20 antigen)-(256-264)-peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma-associated antibodies (NY-ESO-1)
Trial: 30786924
Drug: Melanoma-associated antibodies
RxNorm normalized name: (264-l-valine)melanocyte protein pmel 17 (human melanoma-associated me20 antigen)-(256-264)-peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma-associated antibodies (MelanA/MART1)
Trial: 30786924
Drug: Melanoma-associated antibodies
RxNorm normalized name: (264-l-valine)melanocyte protein pmel 17 (human melanoma-associated me20 antigen)-(256-264)-peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma-associated antibodies (gp100)
Trial: 30786924
Drug: Melanoma-associated antibodies
RxNorm normalized name: (264-l-valine)melanocyte protein pmel 17 (human melanoma-associated me20 antigen)-(256-264)-peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma-associated antibodies (TRP1/TYRP1)
Trial: 30786924
Drug: Melanoma-associated antibodies
RxNorm normalized name: (264-l-valine)melanocyte protein pmel 17 (human melanoma-associated me20 antigen)-(256-264)-peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma-associated antibodies (TRP2/TYRP2)
Trial: 29730186
Drug: High volume
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High volume (HV, 350 mL) water load
Trial: 29730186
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume (LV, 50 mL) water load
Trial: 20304499
Drug: CF101 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CF101 (1 mg, orally, twice daily for 12 weeks)
Trial: 20304499
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching vehicle-filled pills, orally, twice daily for 12 weeks)
Trial: 19030213
Drug: GOS formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GOS formula (0.24 g/100 mL)
Trial: 2964344
Drug: Erythromycin 2
RxNorm normalized name: erythromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 2 percent gel
Trial: 24001291
Drug: Pre-treatment predictors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment predictors
Trial: 24001291
Drug: In-treatment predictors
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment predictors
Trial: 18211998
Drug: Rectal acetaminophen
RxNorm normalized name: acetaminophen Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal acetaminophen 40 mg kg(‐1)
Trial: 18211998
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen 15 mg kg(‐1)
Trial: 12757988
Drug: Repaglinide (2-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (2-4 mg/day)
Trial: 12757988
Drug: Metformin (1500-2500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1500-2500 mg/day)
Trial: 10490724
Drug: Filgrastim (G‐CSF)
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim (G‐CSF) administered subcutaneously at a dose of 5 microg/kg body weight/day from day +5 after PBSC infusion
Trial: 10490724
Drug: Filgrastim (G‐CSF)
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim (G‐CSF)
Trial: 1770184
Drug: Psychostimulants (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychostimulants (two doses)
Trial: 6792958
Drug: Isotonic intravenous
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotonic intravenous infusions of dextrose (IV)
Trial: 31984655
Drug: eluxadoline 100
RxNorm normalized name: eluxadoline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eluxadoline 100 mg twice daily
Trial: 23169470
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (2 capsules daily, 480 mg containing 1.2 mg of S-allylcysteine)
Trial: 23169470
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (4 capsules daily, 960 mg containing 2.4 mg of S-allylcysteine)
Trial: 23169470
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (1 capsule daily, 240 mg containing 0.6 mg of S-allylcysteine)
Trial: 21215788
Drug: Chlorhexidine MMP-inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine MMP-inhibitor
Trial: 17003731
Drug: Electromyographic (EMG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electromyographic (EMG) responses from the facial nerve in experienced implant users (Nucleus 24)
Trial: 10938684
Drug: Fibrinolytic agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolytic agent (n = 43)
Trial: 10938684
Drug: Anticoagulant agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant agent (n = 4)
Trial: 10938684
Drug: Neuroprotective drugs
RxNorm normalized name: NEUROPROTECTIN D1
DrugBank: AP-001 (DB18511)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroprotective drugs (n = 25)
Trial: 10938684
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment expectations
Trial: 8653992
Drug: Oral TPGS
RxNorm normalized name: TPGS
DrugBank: Tocofersolan (DB11635)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral TPGS (2.6 IU/kg) with cyclosporine (10mg/kg)
Trial: 8653992
Drug: Oral cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporine (10mg/kg) without TPGS
Trial: 1306665
Drug: Oral indomethacin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral indomethacin, 1 mg/kg per dose, three times a day for 7 days
Trial: 1306665
Drug: Oral chloramphenicol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral chloramphenicol, 30 mg/kg per day, in four divided doses for 7 days
Trial: 1306665
Drug: Oral indomethacin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral indomethacin, 1 mg/kg per dose, three times a day for 7 days (after chloramphenicol)
Trial: 6391137
Drug: Poster contemplation
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poster contemplation with hypnotic induction
Trial: 30020461
Drug: Combination detemir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination detemir plus liraglutide
Trial: 18692358
Drug: Radioguided occult
RxNorm normalized name: Homalomena occulta root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioguided occult lesion localization (ROLL) with intra-tumoral injection of Tc99m-labelled macro-aggregate albumin
Trial: 18692358
Drug: Simultaneous sentinel
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous sentinel node biopsy with Tc99m-labelled nanocolloids via periareolar-subdermal injection
Trial: 1416323
Drug: 857 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 857 mg/kg sodium polystyrene sulfonate in 4 mL water/g sodium polystyrene sulfonate (experimental)
Trial: 10756963
Drug: Priming dose
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Priming dose of 15 micrograms/kg cisatracurium followed after 4 min by 85 micrograms/kg cisatracurium
Trial: 6092410
Drug: L5‐OH‐triptophan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L5‐OH‐triptophan (20 mg iv)
Trial: 6092410
Drug: L5‐OH‐triptophan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L5‐OH‐triptophan (40 mg iv)
Trial: 6092410
Drug: L5‐OH‐triptophan (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L5‐OH‐triptophan (200 mg orally)
Trial: 6092410
Drug: L5‐OH‐triptophan (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L5‐OH‐triptophan (400 mg orally)
Trial: 6092410
Drug: Fluoxetine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (15 mg orally)
Trial: 6092410
Drug: Fluoxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (30 mg orally)
Trial: 6092410
Drug: Methysergide (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methysergide (3 X 2.8 mg orally)
Trial: 30281066
Drug: GBS III-TT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GBS III-TT conjugate vaccine
Trial: 30281066
Drug: Tetanus diphtheria
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus diphtheria toxoid vaccine
Trial: 11815957
Drug: TLC D‐99
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TLC D‐99 (75 mg/m(2))
Trial: 11815957
Drug: Doxorubicin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (75 mg/m(2))
Trial: 9952144
Drug: Fentanyl 3
RxNorm normalized name: FENTANYL 37.5MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 3 ng/ml
Trial: 9952144
Drug: Fentanyl 6
RxNorm normalized name: FENTANYL 62.5MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 6 ng/ml
Trial: 2248757
Drug: Bopindolol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bopindolol (1 mg once daily)
Trial: 31173341
Drug: Combined dose
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined dose of 50-60 min of aerobic and resistance exercise (COMB)
Trial: 31336456
Drug: Radiofrequency and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency and Ultrasound (RF/US) combined with a low calorie diet, administered twice a week for 5 weeks
Trial: 23582868
Drug: Switch to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch to another SSRI or venlafaxine, with or without the addition of cognitive behavior therapy (CBT)
Trial: 17822340
Drug: Atomoxetine once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine once daily
Trial: 9783935
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg tamsulosin
Trial: 11483141
Drug: naltrexone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naltrexone treatment plus contingency management (CM)
Trial: 11483141
Drug: naltrexone treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naltrexone treatment, CM, plus significant other involvement (SO)
Trial: 11483141
Drug: standard naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard naltrexone treatment
Trial: 9740088
Drug: MET +
RxNorm normalized name: Metformin
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: MET + DEX (10 mg*4 and 2 mg*1, orally)
Trial: 9740088
Drug: TRO (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRO (5 mg*1, orally)
Trial: 9740088
Drug: TRO +
RxNorm normalized name: Tromethamine
DrugBank: Tromethamine (DB03754)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRO + MET (5 mg*1 and 10 mg*2, orally)
Trial: 9740088
Drug: TRO +
RxNorm normalized name: Tromethamine
DrugBank: Tromethamine (DB03754)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRO + MET + DEX (5 mg*1, 10 mg*2, and 2 mg*1, orally)
Trial: 9740088
Drug: CHL +
RxNorm normalized name: CHLORIDE
DrugBank: Chloride ion (DB14547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHL + DEX (25 mg*2 and 2 mg*1, orally)
Trial: 9740088
Drug: TRO +
RxNorm normalized name: Tromethamine
DrugBank: Tromethamine (DB03754)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRO + CHL (5 mg*1 and 12.5 mg*2, orally)
Trial: 9740088
Drug: TRO +
RxNorm normalized name: Tromethamine
DrugBank: Tromethamine (DB03754)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRO + CHL + DEX (5 mg*1, 12.5 mg*2, and 2 mg*1, orally)
Trial: 16885182
Drug: Ibuprofen (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (1200 mg daily for 14 days)
Trial: 14687223
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + SDD (20 mg bid)
Trial: 14687223
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + placebo (20 mg bid)
Trial: 9476468
Drug: Nicotine plus
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine plus cisapride (5 mg)
Trial: 9476468
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (14 mg/day)
Trial: 7958682
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g of fish oil per day
Trial: 7958682
Drug: 5.1 g
RxNorm normalized name: POVIDONE-IODINE 5.1 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.1 g of fish oil per day
Trial: 7958682
Drug: 7.7 g
RxNorm normalized name: somatropin 13 % (1 gram/7.7 gram) MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.7 g of fish oil per day
Trial: 7958682
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g of fish oil per day (in subsequent study with 15 patients)
Trial: 28589618
Drug: Pimecrolimus cream
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimecrolimus cream 1% twice daily for 2 weeks, then moisturizer cream twice daily for 2 weeks
Trial: 28589618
Drug: Pimecrolimus cream
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimecrolimus cream 1% twice daily for 2 weeks, then once daily for another 2 weeks
Trial: 28589618
Drug: Pimecrolimus cream
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimecrolimus cream 1% twice daily for 4 weeks
Trial: 20067513
Drug: Fluvastatin 80
RxNorm normalized name: fluvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 80 mg alone
Trial: 20067513
Drug: Fluvastatin 80
RxNorm normalized name: fluvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 80 mg plus Ezetimibe 10 mg
Trial: 18753727
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with amiodarone (100-200 mg/day) and enalapril (5 mg/day)
Trial: 12207166
Drug: Iodized oil
RxNorm normalized name: ethiodized oil
DrugBank: Ethiodized oil (DB00965)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodized oil (200 mg iodine)
Trial: 9105549
Drug: Cefodizime 1
RxNorm normalized name: cefodizime
DrugBank: Cefodizime (DB13470)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime 1 g b.i.d. (median 7 days) in study A
Trial: 9105549
Drug: Cefodizime 2
RxNorm normalized name: cefodizime
DrugBank: Cefodizime (DB13470)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime 2 g once daily (median 6 days) in study B
Trial: 15883432
Drug: Boiled and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boiled and mashed orange-fleshed sweet potato (OFSP), 125 g daily for 53 school days, providing 1031 retinol activity equivalents/d as beta-carotene.
Trial: 21484965
Drug: Infliximab 5
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 5 or 10 mg/kg
Trial: 8790023
Drug: Lamifiban (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamifiban (high doses)
Trial: 8790023
Drug: Lamifiban (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamifiban (highest dose)
Trial: 8790023
Drug: Lamifiban (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamifiban (all doses)
Trial: 27407053
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of extended-release niacin with 40 mg of laropiprant daily
Trial: 11037739
Drug: 5‐isosorbide‐mononitrate (5‐ISMN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐isosorbide‐mononitrate (5‐ISMN) 30 mg three times daily for 7 days
Trial: 11037739
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of glyceryl trinitrate for 20 minutes
Trial: 9354191
Drug: Oral 5-ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 5-ASA 3 g/day
Trial: 8247308
Drug: Nicardipine Retard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine Retard (40 mg twice a day)
Trial: 2880810
Drug: Nadolol +
RxNorm normalized name: Nadolol
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nadolol + HCTZ 50 mg b.i.d.
Trial: 2880810
Drug: Propranolol +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol + HCTZ 50 mg b.i.d.
Trial: 2880810
Drug: HCTZ 50
RxNorm normalized name: HCTZ 50 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 50 mg b.i.d. + placebo
Trial: 30286851
Drug: Oxycodone (OXY)
RxNorm normalized name: oxycodone hydrochloride Oral Tablet [M-Oxy]
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone (OXY) 5 mg (Open CTR group)
Trial: 30286851
Drug: Ibuprofen (IBU)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBU) 600 mg (Open CTR group)
Trial: 30286851
Drug: Acetaminophen (ACE)
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (ACE) 500 mg (Open CTR group)
Trial: 26813970
Drug: Combination marker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination marker including serum glycan profiles
Trial: 24777164
Drug: Digital Rectal
RxNorm normalized name: BD Thermometer Digital Rectal (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital Rectal Evacuation (DE)
Trial: 24777164
Drug: Transanal Irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transanal Irrigation (TAI) with 500 ml
Trial: 22406126
Drug: Senofilcon A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senofilcon A (ACUVUE® OASYS® with HYDRACLEAR® Plus) worn on a daily wear basis and replaced every 2 weeks
Trial: 18390450
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (single drug formulations)
Trial: 6547101
Drug: Day Nurse
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Day Nurse (single dose)